SYS-CON MEDIA Authors: Bob Gourley, RealWire News Distribution, Kevin Remde, Gathering Clouds

News Feed Item

2012-0909 - New Listing - RepliCel Life Sciences Inc. (RP)

TORONTO, Sept. 27, 2012 /CNW/ - RepliCel Life Sciences Inc.'s common shares (RP) have been approved for listing on CNSX.

RepliCel is developing and patenting a new hair follicle cell replication technology that has the potential to become the first autologous cellular treatment for hair loss in men and women.

Listing and disclosure documents will be available in the Listings Disclosure Hall .

Trading Date: Monday, October 1, 2012
Symbol: RP
CUSIP: 76027P 10 3
ISIN: CA 76027P 10 3 6

SOURCE Canadian National Stock Exchange (CNSX)

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.